Cellular crosstalk in chronic kidney disease

Cellular crosstalk in chronic kidney disease - Cell-CKD

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028621

Enrollment

1920

Registered

2022-03-30

Start date

2022-12-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease Cardiovascular disease

Interventions

Group 1: Blood samples will be analyzed in patients with chronic kidney disease (Arm 1: CKD stage 3, stage 4, stage 5, stage 5 on dialysis). Group 2: Blood samples will be analyzed in healthy controls

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Hemodynamically stable patients with chronic kidney disease stage 3, 4 or 5. - Hemodynamically stable patients with chronic kidney disease and hemodialysis or peritoneal dialysis. - Hemodynamically stable patients with cardiovascular disease

Exclusion criteria

Exclusion criteria: - Hemoglobin value lower than 10 g/dL. - Exclusion of minors, pregnant women, and those unable to consent. - A contagious chronic viral disease.

Design outcomes

Primary

Measure	Time frame
Basic research: analysis of mechanisms of increased cardiovascular risk in CKD patients.	—

Countries

Germany

Contacts

Public ContactHeidi Noels

Universitätsklinikum Aachen

hnoels@ukaachen.de+492418037147

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026